Aurobindo Pharma share up nearly 2% on USFDA approval for nasal spray
The share touched a 52-week high of Rs 1,177 on January 30, 2024 and a 52-week low of Rs 466 on March 21, 2023.20-03-2024
20-03-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Submission of Press Release in connection with US FDA approval for Mometasone Furoate Monohydrate Nasal Spray19-03-2024
AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate18-03-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Curateq Biologics Private Limited, a wholly owned subsidiary pf the Company announces the successful Phase-1 clinical study outcome of their BP11 producte (a biosimilar to Xolair).15-03-2024
Aurobindo Pharma trades 2% down as US FDA spots issues in Telangana unit
Aurobindo Pharma subsidiary's Telangana plant was slapped with 7 observations by the US FDA after its inspection of the unit from February 19-29.15-03-2024
AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information of issue of letter of confirmation.14-03-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation
Weblink of Investor Presentation13-03-2024
Aurobindo Pharma restarts aseptic product distribution; shares trade higher
The share touched a 52-week high of Rs 1,177.00 and a 52-week low of Rs 443.15 on 30 January, 2024 and 14 March, 2023, respectively.13-03-2024
AUROBINDO PHARMA LTD. - 524804 - Restarting Of Distribution Of Aseptic Products Manufactured At Unit III Of Eugia Pharma Specialities Ltd., A Wholly Owned Subsidiary
Intimation about restarting of distribution of aseptic products, that was temporarily stopped, manufactured at Unit III of Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company12-03-2024
AUROBINDO PHARMA LTD. - 524804 - Acceptance Of Compliance With WHO GMP By WHO Prequalification Unit (PQT) Inspection Services Team (INS) For APL Healthcare Limited, Unit IV
Acceptance of compliance with WHO GMP by WHO Prequalification Unit (PQT) Inspection Services Team (INS) for Unit IV of APL Healthcare Limited, a 100% subsidiary11-03-2024